Trials / Not Yet Recruiting
Not Yet RecruitingNCT06901830
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Orthopedic Surgery
A PhaseⅡ, Randomized, Double-Blind, Placebo- and Active- Controlled Study of YZJ-4729 Tartrate Injection for the Treatment of Moderate to Severe Pain After Orthopedic Surgery
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following Orthopedic surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YZJ-4729 | Loading dose + demand dose |
| DRUG | Placebo Comparator: Saline | Loading dose + demand dose |
| DRUG | Active Comparator: Morphine | Loading dose + demand dose |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2025-10-01
- Completion
- 2025-11-01
- First posted
- 2025-03-30
- Last updated
- 2025-03-30
Locations
21 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06901830. Inclusion in this directory is not an endorsement.